— Dostarlimab (Jemperli) approved with chemotherapy for dMMR or MSI-high cancers · Medical News From Around the Web · Medical News From Around the Web.
FDA Approves New Frontline Endometrial Cancer Regimen, First in Decades
Share This Story, Choose Your Platform!
About the Author:
